Clinical Trial

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial

Study acronym: OCD-VRET2
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-subject design for comparison. Patients first complete informed consent and baseline questionnaires and are placed on a waiting list for five weeks. After this period, they are reassigned to the active (experimental) group, which will receive five sessions of exposure therapy in virtual reality over a subsequent five-week period. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.
Trial Details
NCT Number NCT07206199
Lead Sponsor National Institute of Mental Health, Czech Republic
Conditions Obsessive-compulsive Disorder
Enrollment 30 participants
Start Date 2024-03-20
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-03